Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
18
18 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CHO Cellrecombinant zoster vaccine, Recombinant Respiratory Syncytial Virus VaccinePhase 39 trials
MAXVAX Biotechnology Limited Liability Company · Herpes Zoster, Respiratory Syncytial Virus (RSV), Herpes Zoster (HZ)
- RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials
Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult
- RSVpreF VaccinePhase 33 trials
Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)
- RSVPreF3 OA investigational vaccinePhase 33 trials
GSK · Respiratory Syncytial Virus Infections
- RSVPreF3 OA vaccinePhase 32 trials
GSK · Respiratory Syncytial Virus Infections
- su vaccineRZVPhase 32 trials
GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)
- TNM001Phase 32 trials
Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections
- zelicapavirPhase 32 trials
Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)
- ZiresovirAK0529Phase 32 trials
Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections
- LYB005Phase 31 trial
Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine
- Adjuvanted RSVPreF3 vaccinePhase 22 trials
GSK · Cardiovascular Disease, Respiratory Syncytial Virus Infections
- hMPV vaccinePhase 22 trials
Sanofi · Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization, Healthy Volunteers
- RSV vaccine candidatePhase 22 trials
Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization
- ABO1105Phase 21 trial
Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus
- AZD6489Phase 21 trial
AstraZeneca · RSV Respiratory Syncytial Virus
- BLB-201PIV5-vectored RSV VaccinePhase 21 trial
Blue Lake Biotechnology Inc. · Respiratory Syncytial Virus Infections
- SCTV02Phase 21 trial
Sinocelltech Ltd. · Respiratory Syncytial Virus
- SYH2066Phase 21 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.